193 related articles for article (PubMed ID: 18953480)
1. Guggulsterone, an anti-inflammatory phytosterol, inhibits tissue factor and arterial thrombosis.
Gebhard C; Stämpfli SF; Gebhard CE; Akhmedov A; Breitenstein A; Camici GG; Holy EW; Lüscher TF; Tanner FC
Basic Res Cardiol; 2009 May; 104(3):285-94. PubMed ID: 18953480
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents.
Camici GG; Steffel J; Akhmedov A; Schafer N; Baldinger J; Schulz U; Shojaati K; Matter CM; Yang Z; Lüscher TF; Tanner FC
Circulation; 2006 Oct; 114(14):1512-21. PubMed ID: 17000906
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone inhibits arterial thrombus formation and tissue factor translation.
Breitenstein A; Stämpfli SF; Camici GG; Akhmedov A; Ha HR; Follath F; Bogdanova A; Lüscher TF; Tanner FC
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2231-8. PubMed ID: 18974383
[TBL] [Abstract][Full Text] [Related]
4. Dietary α-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activation.
Holy EW; Forestier M; Richter EK; Akhmedov A; Leiber F; Camici GG; Mocharla P; Lüscher TF; Beer JH; Tanner FC
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1772-80. PubMed ID: 21571683
[TBL] [Abstract][Full Text] [Related]
5. Histamine induces tissue factor expression: implications for acute coronary syndromes.
Steffel J; Akhmedov A; Greutert H; Lüscher TF; Tanner FC
Circulation; 2005 Jul; 112(3):341-9. PubMed ID: 16009787
[TBL] [Abstract][Full Text] [Related]
6. Laminin receptor activation inhibits endothelial tissue factor expression.
Holy EW; Stämpfli SF; Akhmedov A; Holm N; Camici GG; Lüscher TF; Tanner FC
J Mol Cell Cardiol; 2010 Jun; 48(6):1138-45. PubMed ID: 19712679
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells.
Steffel J; Akhmedov A; Fähndrich C; Ruschitzka F; Lüscher TF; Tanner FC
Biochem Biophys Res Commun; 2006 Oct; 349(2):597-603. PubMed ID: 16949034
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation.
Stähli BE; Camici GG; Steffel J; Akhmedov A; Shojaati K; Graber M; Lüscher TF; Tanner FC
Circ Res; 2006 Jul; 99(2):149-55. PubMed ID: 16794185
[TBL] [Abstract][Full Text] [Related]
9. Cardiac glycosides regulate endothelial tissue factor expression in culture.
Stähli BE; Breitenstein A; Akhmedov A; Camici GG; Shojaati K; Bogdanov N; Steffel J; Ringli D; Lüscher TF; Tanner FC
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2769-76. PubMed ID: 18029910
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design.
Steffel J; Latini RA; Akhmedov A; Zimmermann D; Zimmerling P; Lüscher TF; Tanner FC
Circulation; 2005 Sep; 112(13):2002-11. PubMed ID: 16172265
[TBL] [Abstract][Full Text] [Related]
11. Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells.
Holy EW; Akhmedov A; Lüscher TF; Tanner FC
J Mol Cell Cardiol; 2009 Feb; 46(2):234-40. PubMed ID: 19014947
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation.
Steffel J; Hermann M; Greutert H; Gay S; Lüscher TF; Ruschitzka F; Tanner FC
Circulation; 2005 Apr; 111(13):1685-9. PubMed ID: 15795326
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive Intestinal Peptide and pituary adenylate cyclase-activating polypeptide inhibit tissue factor expression in monocyte in vitro and in vivo.
Lv B; Tang Y; Chen F; Xiao X
Shock; 2009 Feb; 31(2):185-91. PubMed ID: 18650785
[TBL] [Abstract][Full Text] [Related]
14. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
Breitenstein A; Stein S; Holy EW; Camici GG; Lohmann C; Akhmedov A; Spescha R; Elliott PJ; Westphal CH; Matter CM; Lüscher TF; Tanner FC
Cardiovasc Res; 2011 Feb; 89(2):464-72. PubMed ID: 20978007
[TBL] [Abstract][Full Text] [Related]
15. Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-alpha and its possible role in wound healing.
Fu X; Han B; Cai S; Lei Y; Sun T; Sheng Z
Wound Repair Regen; 2009; 17(2):185-91. PubMed ID: 19320886
[TBL] [Abstract][Full Text] [Related]
16. Role of oxidation-triggered activation of JNK and p38 MAPK in black tea polyphenols induced apoptotic death of A375 cells.
Bhattacharya U; Halder B; Mukhopadhyay S; Giri AK
Cancer Sci; 2009 Oct; 100(10):1971-8. PubMed ID: 19594545
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance.
Wu J; Stevenson MJ; Brown JM; Grunz EA; Strawn TL; Fay WP
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):698-704. PubMed ID: 18276908
[TBL] [Abstract][Full Text] [Related]
19. MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin.
Kim JE; Kwon JY; Lee DE; Kang NJ; Heo YS; Lee KW; Lee HJ
Biochem Pharmacol; 2009 Feb; 77(3):412-21. PubMed ID: 19026990
[TBL] [Abstract][Full Text] [Related]
20. Emodin suppression of ocular surface inflammatory reaction.
Kitano A; Saika S; Yamanaka O; Ikeda K; Okada Y; Shirai K; Reinach PS
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5013-22. PubMed ID: 17962452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
